• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童及青少年肾脏替代治疗的时机与方式

Timing and Modality of Kidney Replacement Therapy in Children and Adolescents.

作者信息

Thumfart Julia, Wagner Steffen, Kirchner Marietta, Azukaitis Karolis, Bayazit Aysun K, Obrycki Lukasz, Canpolat Nur, Bulut Ipek Kaplan, Duzova Ali, Anarat Ali, Bessenay Lucie, Shroff Rukshana, Paripovic Dusan, Sever Lale, Candan Cengiz, Lugani Francesca, Yilmaz Alev, Yalcinkaya Fatos, Arbeiter Klaus, Kiyak Aysel, Zurowska Aleksandra, Galiano Matthias, Querfeld Uwe, Melk Anette, Schaefer Franz

机构信息

Department of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité Universitätsmedizin, Berlin, Germany.

BHT Berliner Hochschule für Technik, Berlin, Germany.

出版信息

Kidney Int Rep. 2024 Jun 12;9(9):2750-2758. doi: 10.1016/j.ekir.2024.06.009. eCollection 2024 Sep.

DOI:10.1016/j.ekir.2024.06.009
PMID:39291215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11403031/
Abstract

INTRODUCTION

The choice and timing of kidney replacement therapy (KRT) is influenced by clinical factors, laboratory features, feasibility issues, family preferences, and clinicians' attitudes. We analyzed the factors associated with KRT modality and timing in a multicenter, multinational prospective pediatric cohort study.

METHODS

A total of 695 pediatric patients with chronic kidney disease (CKD) enrolled into the Cardiovascular Comorbidity in Children with CKD (4C) study at age 6 to 17 years with estimated glomerular filtration rate (eGFR) of 10 to 60 ml/min per 1.73 m were investigated. Competing risk regression was performed to identify factors associated with initiation of dialysis or preemptive transplantation (Tx), including primary renal diagnosis, demographics, anthropometrics, and laboratory parameters.

RESULTS

During the 8-year observation period, 342 patients (49%) started KRT. Of these, 200 patients started dialysis, whereas 142 patients underwent preemptive Tx. A lower eGFR at enrolment (Hazard ratio [HR]: 0.76 [95% confidence interval: 0.74-0.78]), a steeper eGFR slope (HR: 0.90 [0.85-0.95], and a higher systolic blood pressure SD score (SDS) (HR: 2.07 [1.49-2.87]) increased the likelihood of KRT initiation. Patients with glomerulopathies were more likely to start dialysis than children with congenital anomalies of the kidneys and urinary tracts (CAKUT) (HR: 3.81 [2.52-5.76]). Lower body mass index (BMI) SDS (HR: 0.73 [0.6-0.89]) and lower hemoglobin (HR: 0.8 [0.72-0.9]) were associated with higher likelihood of dialysis. A significant center effect was observed, accounting for 6.8% (dialysis) to 8.7% (preemptive Tx) of explained variation.

CONCLUSION

The timing and choice of KRT in pediatric patients is influenced by the rate of kidney function loss, the underlying kidney disease, nutritional status, blood pressure, anemia and center-specific factors.

摘要

引言

肾脏替代治疗(KRT)的选择和时机受临床因素、实验室指标、可行性问题、家庭偏好及临床医生态度的影响。我们在一项多中心、跨国前瞻性儿科队列研究中分析了与KRT方式和时机相关的因素。

方法

共有695例年龄在6至17岁、估计肾小球滤过率(eGFR)为每1.73平方米10至60毫升/分钟的慢性肾脏病(CKD)儿科患者纳入儿童CKD心血管合并症(4C)研究。采用竞争风险回归分析确定与开始透析或抢先移植(Tx)相关的因素,包括原发性肾脏诊断、人口统计学、人体测量学和实验室参数。

结果

在8年观察期内,342例患者(49%)开始KRT。其中,200例患者开始透析,142例患者接受抢先Tx。入组时较低的eGFR(风险比[HR]:0.76[95%置信区间:0.74 - 0.78])、较陡的eGFR斜率(HR:0.90[0.85 - 0.95])以及较高的收缩压标准差评分(SDS)(HR:2.07[1.49 - 2.87])增加了开始KRT的可能性。肾小球病患者比先天性肾脏和尿路异常(CAKUT)患儿更有可能开始透析(HR:3.81[2.52 - 5.76])。较低的体重指数(BMI)SDS(HR:0.73[0.6 - 0.89])和较低的血红蛋白(HR:0.8[0.72 - 0.9])与更高的透析可能性相关。观察到显著的中心效应,占解释变异的6.8%(透析)至8.7%(抢先Tx)。

结论

儿科患者KRT的时机和选择受肾功能丧失率、潜在肾脏疾病、营养状况、血压、贫血及中心特异性因素影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b4/11403031/0d08fe5dfea4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b4/11403031/fb01f8349766/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b4/11403031/88981cdfa20b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b4/11403031/0d08fe5dfea4/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b4/11403031/fb01f8349766/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b4/11403031/88981cdfa20b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22b4/11403031/0d08fe5dfea4/gr2.jpg

相似文献

1
Timing and Modality of Kidney Replacement Therapy in Children and Adolescents.儿童及青少年肾脏替代治疗的时机与方式
Kidney Int Rep. 2024 Jun 12;9(9):2750-2758. doi: 10.1016/j.ekir.2024.06.009. eCollection 2024 Sep.
2
Timing of Kidney Replacement Therapy among Children and Young Adults.儿童和青年人群的肾脏替代治疗时机。
Clin J Am Soc Nephrol. 2023 Aug 1;18(8):1041-1050. doi: 10.2215/CJN.0000000000000204. Epub 2023 Jun 6.
3
Hemodialysis血液透析
4
Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study.COVID-19 相关急性肾损伤行透析治疗的危重症患者的肾脏恢复和死亡:STOP-COVID 队列研究。
Am J Kidney Dis. 2022 Mar;79(3):404-416.e1. doi: 10.1053/j.ajkd.2021.11.004. Epub 2021 Dec 4.
5
CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.CKD 进展和男女患者死亡率:瑞典全国研究。
Am J Kidney Dis. 2021 Aug;78(2):190-199.e1. doi: 10.1053/j.ajkd.2020.11.026. Epub 2021 Jan 9.
6
Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children.儿童血清可溶性尿激酶受体水平与肾脏疾病进展的关联
JAMA Pediatr. 2017 Nov 6;171(11):e172914. doi: 10.1001/jamapediatrics.2017.2914.
7
Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.血清钾与 CKD 4-5 期老年人的死亡或肾脏替代治疗风险:8 年随访。
Am J Kidney Dis. 2023 Sep;82(3):257-266.e1. doi: 10.1053/j.ajkd.2023.03.008. Epub 2023 May 12.
8
Trajectories of eGFR after kidney transplantation according to trajectories of eGFR prior to kidney replacement therapies in children with chronic kidney disease.根据慢性肾脏病儿童肾替代治疗前 eGFR 轨迹,分析肾移植后 eGFR 轨迹。
Pediatr Nephrol. 2023 Dec;38(12):4157-4164. doi: 10.1007/s00467-023-06056-z. Epub 2023 Jun 23.
9
Association of the Urine-to-Plasma Urea Ratio With CKD Progression.尿/血浆尿素比值与 CKD 进展的关系。
Am J Kidney Dis. 2023 Apr;81(4):394-405. doi: 10.1053/j.ajkd.2022.09.010. Epub 2022 Nov 7.
10
Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.患有糖尿病肾病和非糖尿病肾病的患者慢性肾脏病进展的预后和危险因素:一项前瞻性队列 CKD-ROUTE 研究。
Ren Fail. 2022 Dec;44(1):1309-1318. doi: 10.1080/0886022X.2022.2106872.

本文引用的文献

1
Chronic kidney disease mineral bone disorder in childhood and young adulthood: a 'growing' understanding.儿童及青年期慢性肾脏病-矿物质和骨异常:逐渐深入的认识
Pediatr Nephrol. 2024 Mar;39(3):723-739. doi: 10.1007/s00467-023-06109-3. Epub 2023 Aug 25.
2
Timing of Kidney Replacement Therapy among Children and Young Adults.儿童和青年人群的肾脏替代治疗时机。
Clin J Am Soc Nephrol. 2023 Aug 1;18(8):1041-1050. doi: 10.2215/CJN.0000000000000204. Epub 2023 Jun 6.
3
Diagnosis and management of mineral and bone disorders in infants with CKD: clinical practice points from the ESPN CKD-MBD and Dialysis working groups and the Pediatric Renal Nutrition Taskforce.
CKD 婴儿矿物质和骨代谢紊乱的诊断和管理:ESPN CKD-MBD 和透析工作组以及儿科肾脏营养工作组的临床实践要点。
Pediatr Nephrol. 2023 Sep;38(9):3163-3181. doi: 10.1007/s00467-022-05825-6. Epub 2023 Feb 14.
4
Results in the ESPN/ERA-EDTA Registry suggest disparities in access to kidney transplantation but little variation in graft survival of children across Europe.ESPN/ERA-EDTA登记处的结果表明,欧洲各地儿童在肾移植可及性方面存在差异,但在移植物存活率方面差异不大。
Kidney Int. 2020 Aug;98(2):464-475. doi: 10.1016/j.kint.2020.03.029. Epub 2020 Apr 26.
5
The Profile of Timing Dialysis Initiation in Patients with End-stage Renal Disease in China: A Cohort Study.中国终末期肾病患者开始透析时机的特征:一项队列研究。
Kidney Blood Press Res. 2020;45(2):180-193. doi: 10.1159/000504671. Epub 2020 Jan 30.
6
Mode of initial renal replacement therapy and transplant outcomes in the chronic kidney disease in children (CKiD) study.初始肾脏替代治疗方式与慢性肾脏病儿童(CKiD)研究中的移植结局。
Pediatr Nephrol. 2020 Jun;35(6):1015-1021. doi: 10.1007/s00467-019-04416-2. Epub 2019 Dec 3.
7
Should we abandon GFR in the decision to initiate chronic dialysis?我们是否应该在决定开始慢性透析时放弃 GFR?
Pediatr Nephrol. 2020 Sep;35(9):1593-1600. doi: 10.1007/s00467-019-04333-4. Epub 2019 Aug 15.
8
Higher eGFR at Dialysis Initiation Is Not Associated with a Survival Benefit in Children.透析开始时较高的 eGFR 与儿童的生存获益无关。
J Am Soc Nephrol. 2019 Aug;30(8):1505-1513. doi: 10.1681/ASN.2018111130. Epub 2019 Jul 18.
9
Association between timing of dialysis initiation and clinical outcomes in the paediatric population: an ESPN/ERA-EDTA registry study.儿童人群中透析起始时机与临床结局的关联:ESPEN/ERA-EDTA 登记研究。
Nephrol Dial Transplant. 2019 Nov 1;34(11):1932-1940. doi: 10.1093/ndt/gfz069.
10
Estimated GFR at Dialysis Initiation and Mortality in Children and Adolescents.透析开始时的估算肾小球滤过率与儿童和青少年的死亡率。
Am J Kidney Dis. 2019 Jun;73(6):797-805. doi: 10.1053/j.ajkd.2018.12.038. Epub 2019 Mar 2.